Updates in the Management of Chronic Kidney Disease and Type 2 Diabetes

home / peer-exchange / updates-in-the-management-of-chronic-kidney-disease-and-type-2-diabetes

Clinician and payer insight regarding complexities managing patients with chronic kidney disease and type 2 diabetes, and best practices utilizing newer treatment options.

Episodes

September 30th 2021EP. 1: Characteristics of Chronic Kidney Disease

Neil B. Minkoff, MD;Rajiv Agarwal, MD, MS;Eugene Wright Jr., MD

Drs Rajiv Agarwal and Eugene Wright Jr. highlight risk factors associated with chronic kidney disease and react to concerns surrounding the assessment and treatment of patients.

September 30th 2021EP. 2: Assessment and Staging of Chronic Kidney Disease

Neil B. Minkoff, MD;George L. Bakris, MD;Eugene Wright Jr., MD

Diagnostic criteria and special considerations of nephrologists when assessing patient kidney function and diagnosing chronic kidney disease.

October 7th 2021EP. 3: Counseling Patients About Chronic Kidney Disease

Neil B. Minkoff, MD;Rajiv Agarwal, MD, MS;Eugene Wright Jr., MD;George L. Bakris, MD

Strategies to help clinicians talk with patients about chronic kidney disease staging and what to expect in terms of prognosis.

October 7th 2021EP. 4: Clinical and Economic Burden of Chronic Kidney Disease

Neil B. Minkoff, MD;Eugene Wright Jr., MD;Rajiv Agarwal, MD, MS;George L. Bakris, MD

Financial and clinical concerns surrounding the burden of chronic kidney disease progression, as well as social determinants that factor into managing the condition in the community.

October 14th 2021EP. 5: Preventing Progression of Chronic Kidney Disease

Neil B. Minkoff, MD;Rajiv Agarwal, MD, MS;George L. Bakris, MD;Eugene Wright Jr., MD

A panel of clinicians explain why action is needed to help prevent the risk of progression of chronic kidney disease.

October 14th 2021EP. 6: Motivating Patients Who Have CKD and T2DM

Neil B. Minkoff, MD;George L. Bakris, MD;Eugene Wright Jr., MD;Rajiv Agarwal, MD, MS

Strategies that can help clinicians establish and work toward goals when treating patients with chronic kidney disease to help control disease and prevent progression.

October 21st 2021EP. 7: Care Coordination for Patients With CKD and T2DM

Neil B. Minkoff, MD;George L. Bakris, MD;Eugene Wright Jr., MD

Various types of health care professionals who may play a role in treating patients with chronic kidney disease, and recommendations to help overcome barriers that impact risk of disease progression and outcomes for patients.

October 21st 2021EP. 8: Measures to Improve Chronic Kidney Disease

Neil B. Minkoff, MD;George L. Bakris, MD;Eugene Wright Jr., MD

Key takeaways from the National Kidney Foundation’s new HEDIS and MIPS quality measures for patients with chronic kidney disease and type 2 diabetes.

October 28th 2021EP. 9: Early Identification and Management of CKD

Neil B. Minkoff, MD;Eugene Wright Jr., MD;Rajiv Agarwal, MD, MS;George L. Bakris, MD

What better testing strategies and newer quality measures can do to improve patient referrals to nephrologists for earlier intervention of chronic kidney disease.

October 28th 2021EP. 10: Establishing Care Pathways to Manage CKD and T2DM

Neil B. Minkoff, MD;Rajiv Agarwal, MD, MS;George L. Bakris, MD;Eugene Wright Jr., MD

Considerations for establishing balance for the care of patients with chronic kidney disease among all types of care settings.

November 4th 2021EP. 11: Chronic Kidney Disease: Treatment Landscape

Neil B. Minkoff, MD;George L. Bakris, MD;Eugene Wright Jr., MD;Rajiv Agarwal, MD, MS

Therapies used to help treat patients who have chronic kidney disease and type 2 diabetes.

November 4th 2021EP. 12: The FIDELIO-DKD Trial in Chronic Kidney Disease

Neil B. Minkoff, MD;George L. Bakris, MD

George L. Bakris, MD, describes the design and results of the FIDELIO-DKD trial investigating the effect of finerenone on patients with chronic kidney disease.

November 11th 2021EP. 13: Non-steroidal MRAs for Chronic Kidney Disease

Neil B. Minkoff, MD;George L. Bakris, MD;Rajiv Agarwal, MD, MS

What to know in terms of the mechanism of action of non-steroidal MRA finerenone compared with other therapies used to treat patients with chronic kidney disease and type 2 diabetes.

November 11th 2021EP. 14: Implications of FIDELIO-DKD in CKD

Neil B. Minkoff, MD;Eugene Wright Jr., MD

Where data demonstrated by the FIDELIO-DKD study of finerenone for patients with chronic kidney disease may apply in routine clinical practice.

November 15th 2021EP. 15: SGLT2 Inhibitor Use in Chronic Kidney Disease

Neil B. Minkoff, MD;Eugene Wright Jr., MD;George L. Bakris, MD

A panel of clinicians react to limitations surrounding the use of SGLT2 inhibitors for patients with chronic kidney disease and type 2 diabetes.

November 15th 2021EP. 16: Emerging Therapies for Chronic Kidney Disease

Neil B. Minkoff, MD;George L. Bakris, MD;Eugene Wright Jr., MD

An overview of therapies in the pipeline, including other nonsteroidal MRAs, that show potential in treating patients who have chronic kidney disease and type 2 diabetes.

November 15th 2021EP. 17: Optimizing Outcomes for Patients With CKD and T2DM

Neil B. Minkoff, MD;Rajiv Agarwal, MD, MS;Eugene Wright Jr., MD;George L. Bakris, MD

Steps that need to be taken to address unmet needs and optimize outcomes for patients who have chronic kidney disease and type 2 diabetes.

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

Do Not Sell My Information

Terms & Conditions